Angela L. Wirick - Mar 1, 2024 Form 4 Insider Report for AtriCure, Inc. (ATRC)

Role
Chief Financial Officer
Signature
/s/ Angela L. Wirick
Stock symbol
ATRC
Transactions as of
Mar 1, 2024
Transactions value $
$0
Form type
4
Date filed
3/5/2024, 04:46 PM
Previous filing
Aug 8, 2023
Next filing
Mar 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRC Common Stock Award $0 +31K +35.81% $0.00 118K Mar 1, 2024 Direct F1
transaction ATRC Common Stock Award $0 +16.5K +14% $0.00 134K Mar 1, 2024 Direct F2
transaction ATRC Common Stock Options Exercise $84.8K +5K +3.73% $16.95 139K Mar 1, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATRC Non-qualified Stock Option (right to buy) Options Exercise -$84.8K -5K -100% $16.95 0 Mar 1, 2024 Non-qualified Stock Option (right to buy) 5K $16.95 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.
F2 The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met.
F3 These options were granted on July 28, 2014. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.